Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter June 1, 2005

Plasma endothelin-1 and clinical manifestations of neonatal sepsis

  • José Figueras-Aloy , Lilian Gómez-Lopez , J. Manuel Rodríguéz-Miguélez , Yolanda Jordán-García , M. Dolores Salvia-Roiges , Wladimiro Jiménez and Xavier Carbonell-Estrany

Abstract

Aim: To determine whether plasma endothelin-1 (ET-1) relates to clinical manifestations of sepsis in the newborn, especially with systemic hypotension, acidosis, severe hypoxemia (which may represent pulmonary hypertension) and oliguria.

Methods: Prospective study of 35 consecutive newborns with clinical sepsis: 22 with hemoculture-positive (HC+) sepsis and 13 hemoculture-negative (HC–). Plasma ET-1 concentrations were measured within 2 days of the diagnosis of sepsis. SNAP-II severity score was performed at the time of highest clinical severity.

Results: Newborns with HC+ sepsis had higher plasma ET-1 concentrations and SNAP-II scores (especially PO2/FiO2ratio) than HC– septic children. Plasma ET-1 concentrations increased linearly with each item of the SNAP-II score, but only reached significant differences in lowest mean blood pressure (P=0.030), lowest pH (P=0.048), multiple seizures (P=0.010) and lowest urine output (P=0.013). Leukocyte count, immature/total neutrophil ratio and C-reactive protein value were not different. Each item of the SNAP-II score was independently related only to ET-1 level. Oliguria, acidosis and systemic hypotension were more correlated (R2>0.5).

Conclusions: Plasma ET-1 levels in neonatal sepsis are related to the severity of clinical manifestations, especially oliguria, acidosis and systemic hypotension.

:

Corresponding author: Prof. J. Figueras-Aloy, Servicio Neonatología, Hospital Clínic, C/Sabino de Arana 1, 08028-Barcelona/Spain. Tel.: +34-93-2275600, Fax: +34-93-2275605, E-mail:

References

1 Avontuur JA, F Boomsma, AH Van den Meiracker, FH De Jong FH, HA Bruining: Endothelin-1 and blood pressure after inhibition of nitric oxide synthesis in human septic shock. Circulation99 (1999) 271Search in Google Scholar

2 Battistini B, MA Forget, D Laight: Potential roles for endothelins in systemic inflammatory response syndrome with a particular relationship to cytokines. Shock5 (1996) 167Search in Google Scholar

3 Dschietzig T, K Alexiou, M Laule, R Becker, K Schror, G Baumann, F Brunner, K Stangl: Stimulation of pulmonary big endothelin-1 and endothelin-1 by antithrombin III: a rationale for combined application of antithrombin III and endothelin antagonists in sepsis-related acute respiratory distress syndrome? Crit Care Med28 (2000) 2445Search in Google Scholar

4 Figueras-Aloy J, L Gómez, JM Rodríguez-Miguélez, Y Jordán, MD Salvia, W Jiménez, X Carbonell-Estrany: Plasma nitrite–nitrate and endothelin-1 concentrations in neonatal sepsis. Acta Paediatr92 (2003) 582Search in Google Scholar

5 Fujii Y, S Magder, P Cernacek, P Goldberg, Y Guop, SN Hussain: Endothelin receptor blockade attenuates lipopolysaccharide-induced pulmonary nitric oxide production. Am J Respir Crit Care Med161 (2000) 982Search in Google Scholar

6 Hageman JR, MS Caplan: An introduction to the structure and function of inflammatory mediators for clinicians. Clin Perinatol22 (1995) 251Search in Google Scholar

7 Imai T, Y Hirata, T Emori, M Yanagisawa, T Masaki, F Marumo: Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension19 (1992) 753Search in Google Scholar

8 Kohan DE: Role of endothelin and tumour necrosis factor in the renal response to sepsis. Nephrol Dial Transplant9 (1994) 73Search in Google Scholar

9 Marsden PA, BM Brenner: Transcriptional regulation of the endothelin gene by TNF alpha. Am J Physiol262 (1992) C85410.1152/ajpcell.1992.262.4.C854Search in Google Scholar PubMed

10 McMillen MA, ME Cunningham: Origin of endothelin in sepsis. Crit Care Med24 (1996) 721Search in Google Scholar

11 McMillen MA, ME Cunningham: Roles for endothelins in shock. Shock6 (1996) 383Search in Google Scholar

12 Miyauchi T, T Masaki: Pathophysiology of endothelin in the cardiovascular system. Annu Rev Physiol61 (1999) 391Search in Google Scholar

13 Poo JL, W Jiménez, RM Muñoz, M Bosch-Marcé, N Bordas, M Morales-Ruiz, et al.: Chronic blockade of endothelin receptors in cirrhotic rats: hepatic and hemodynamic effects. Gastroenterology116 (1999) 161Search in Google Scholar

14 Richardson DK, JD Corcoran, GJ Escobar, SK Lee, for The Canadian NICU Network, The Kaiser Permanente Neonatal Minimum Data Set Wide Area Network, and The SNAP-II Study Group: SNAP-II and SNAPPE-II: simplified newborn illness severity and mortality risk scores. J Pediatr138 (2001) 92Search in Google Scholar

15 Rosenberg AA, J Kennaugh, SL Koppenhafer, M Loomis, BA Chatfield, SH Abman: Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension. J Pediatr123 (1993) 109Search in Google Scholar

16 Sharma AC, SJ Motew, S Farias, KJ Alden, HB Bosmann, WR Law, et al.: Sepsis alters myocardial and plasma concentrations of endothelin and nitric oxide in rats. J Mol Cell Cardiol29 (1997) 1469Search in Google Scholar

17 Weitzberg E, A Hemsen, A Rudehill, A Modin, M Wanecek, JM Lungberg: Bosentan-improved cardiopulmonary vascular performance and increased plasma levels of endothelin-1 in porcine endotoxin shock. Br J Pharmacol118 (1996) 617Search in Google Scholar

Published Online: 2005-06-01
Published in Print: 2004-11-04

© Walter de Gruyter

Downloaded on 8.6.2024 from https://www.degruyter.com/document/doi/10.1515/JPM.2004.126/html
Scroll to top button